A Clinical Research Study for Sleep-Related Breathing Disorders
Flipping the Switch on Sleep-Related Breathing Disorders
Shallow breathing while you sleep shouldn’t shadow your entire day.
If you live with obesity hypoventilation syndrome or COPD-related hypoventilation, consider exploring your options through research.
Learn more about the NOCTAVA Study today.
See If You May Qualify(Concept 2 — person in bed flipping a light switch inside a lung silhouette)
awaiting SVG/PNG export
You may be able to participate in the NOCTAVA Study if you:
Are 21 to 75 years of age
Have been diagnosed with obesity hypoventilation syndrome or COPD-related hypoventilation
Are not currently using positive airway pressure (PAP) therapy and do not need supplemental oxygen
If you are interested in participating, the study doctor or staff will review additional study criteria with you.
See If You May QualifyAbout the NOCTAVA Study
The NOCTAVA Study is a clinical research study for adults with obesity hypoventilation syndrome or COPD-related hypoventilation. It is looking at whether an investigational medication may help support breathing during sleep.
During the study, participants will be placed by chance into 1 of 3 groups. Two groups will receive different doses of the investigational medication, and 1 group will receive a placebo, which looks like the investigational medication but has no active ingredients. Participants will take the tablets by mouth.
The study will last about 9 weeks and include up to 7 visits: 5 at the study center and 2 by phone. Two study center visits will require an overnight stay. Participants will complete a daily electronic diary at home, wear an activity-monitoring device from screening through Day 35, and use a separate small sleep-monitoring device for 2 nights during the week before each study center visit.
(to come from CTM with the print materials)